-
Posted by
Two Blokes May 19, 2025 -
Filed in
Stock
-
8 views
Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe's assets for $256 million after coming out on top at a bankruptcy auction for the once-sizzling DNA-testing startup.
